SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 84.75+1.3%Sep 15 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bnutman
bobbseytwins2001
CelebrityEquity
Dietman
EMU2
idahoranch1
sysiphus
From: Renmanco8/20/2019 10:04:17 AM
7 Recommendations   of 58323
 
Lots of anxiety here lately. Complaints about taking so long for re-submission and whether Behzad has the skills to run the organization.

First, if I were CEO of a biotech and received a CRL letter, I'd be damn sure to correct everything beyond mere acceptability and strive for better than expected....to show the regulators that I took the wrist slap as serious.

Second, Pehl came from Celgene, hardly a slouch outfit (though even CELG has had issues with filing for drug approvals) My take on Pehl---he lacked regulatory interaction experience and that was what we needed at the time; consequently, he couldn't appreciate the detail required to go into an FDA submission.

Third: Behzad. He moved swiftly to get rid of Pehl. He did have "experience" in dealing with biotechs through his hedge fund so I believe he figured he could at least set the barrier high enough for re-submission to insure no more screw-ups. AND, he put Charles Baum (CEO of Mirati and another large and successful Behzad holding) on the Board, no doubt to offer assistance in doing a correct re-submission. Losing a year in biotech is very dangerous and, in many cases, it can be fatal. I hope we will still have a competitive edge once the re-submission is done....but the jury is out as to whether "silly" will be a viable word until the evidence is further developed.

Like many here, I regret the past mistakes and I remain of the belief that Behzad has figured things out at long last and we will have a successful re-submission. If he fails gain, the game as we know it will be over and the asset auction can begin.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext